"How we treat our patients is how we would treat our family members."
Where I see patients (2)
My reviews
Selected research
-
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis.
Hepatology communications
-
Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease.
Journal of hepatology
-
Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical trials
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steat...
The scale used is NAS - this is the NAFLD (Nonalcoholic Fatty Liver Disease) Activity Score. The NAS was developed to provide a numerical score for patients who most likely have NASH. Accordingly, NAS is the sum of the separate sc...
Recruiting
4.8